EnlivenHealthâ„¢ Revenue and Competitors
Estimated Revenue & Valuation
- EnlivenHealthâ„¢'s estimated annual revenue is currently $60.9M per year.
- EnlivenHealthâ„¢'s estimated revenue per employee is $408,624
Employee Data
- EnlivenHealthâ„¢ has 149 Employees.
- EnlivenHealthâ„¢ grew their employee count by -6% last year.
EnlivenHealthâ„¢'s People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Customer Officer (CCO) | Reveal Email/Phone |
2 | Head Pharmacy Transformation | Reveal Email/Phone |
3 | Senior Director, Marketing | Reveal Email/Phone |
4 | Senior Director, Strategic Accounts | Reveal Email/Phone |
5 | Sr. Director, Business Intelligence, Customer Support & Customer Analytics | Reveal Email/Phone |
6 | Director, Strategic Accounts | Reveal Email/Phone |
7 | Director, Strategic Accounts | Reveal Email/Phone |
8 | Director Strategic Accounts | Reveal Email/Phone |
9 | Director Support | Reveal Email/Phone |
10 | Senior Director Product Management | Reveal Email/Phone |
EnlivenHealthâ„¢ Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $76.6M | 192 | -4% | N/A | N/A |
#2 | $109.4M | 247 | -2% | N/A | N/A |
#3 | $7.8M | 25 | -11% | N/A | N/A |
#4 | $14.3M | 50 | 9% | N/A | N/A |
#5 | $27.3M | 76 | -3% | N/A | N/A |
#6 | $17M | 55 | 2% | N/A | N/A |
#7 | $1.6M | 10 | 25% | N/A | N/A |
#8 | $421.5M | 1115 | N/A | N/A | N/A |
#9 | $29.7M | 92 | 8% | N/A | N/A |
#10 | $58.2M | 177 | 16% | N/A | N/A |
What Is EnlivenHealthâ„¢?
EnlivenHealthâ„¢ is the Omnicell, Inc. division that builds advanced patient/member engagement and communications solutions for retail pharmacies and health plans.
keywords:N/AN/A
Total Funding
149
Number of Employees
$60.9M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $45.1M | 152 | 0% | N/A |
#2 | $7.5M | 152 | 36% | N/A |
#3 | $24.9M | 154 | 3% | N/A |
#4 | $42.8M | 155 | 16% | N/A |
#5 | $25.7M | 156 | 25% | N/A |